This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Assurant Boosts Automation Prospects With OptoFidelity Technology (Revised)
by Zacks Equity Research
AIZ acquires OptoFidelity's technology to benefit the Connected Living business of its Global Lifestyle segment.
EVER Outperforms Industry, Trades at Premium: How to Play the Stock
by Zacks Equity Research
EverQuote remains poised to gain from its exclusive data asset and technology, intensified focus on core P&C markets and strong financial profile.
Bet on Winning DuPont Analysis & Pick 4 Top Stocks
by Sanghamitra Saha
Tap EverQuote (EVER), Casey's General Stores (CASY), AllianceBernstein (AB) and Sprouts Farmers Market (SFM) if you have more faith in DuPont analysis than ROE
Assurant Acquires OptoFidelity & Boosts Automation Prospects
by Zacks Equity Research
AIZ acquires OptoFidelity to benefit the Connected Living business of its Global Lifestyle segment.
ORI Outperforms Industry, Hits 52-Week High: How to Play the Stock
by Zacks Equity Research
Old Republic International gains from solid market presence, low property catastrophe exposure in its General Insurance segment and strong capital position.
Can Principal Financial Balance Growth With Margin Pressures?
by Zacks Equity Research
PFG benefits from retirement leadership, fee-based income, and consistent shareholder returns despite margin pressures.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Root vs. EverQuote: Which Stock Is the Stronger Bet in Insurtech?
by Tanuka De
EverQuote's debt-free growth strategy and AI-powered platform position it well compared to Root in the insurtech race.
Everest Group Is Trading at a Discount: Time to Load Up or Hold Off?
by Zacks Equity Research
EG expands globally, strengthens its balance sheet, and grows steadily, though ROE still trails industry peers.
EVER Rallies 16.3% YTD, Trades at Premium: Should You Buy the Stock?
by Zacks Equity Research
EverQuote leans on AI, data and a stronger auto focus to drive growth, but faces rising costs, stiff competition and regulatory risks.
EverQuote (EVER) Down 2.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ROOT Loses 33% in 3 Months, Trades at a Premium: How to Play the Stock
by Tanuka De
ROOT shares are down 33% in three months, yet the insurer boasts strong profitability, tech-driven growth and analyst optimism.
Do Options Traders Know Something About EverQuote Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to EverQuote stock based on the movements in the options market lately.
Everest Group Trades Below 50-Day SMA: How to Play the Stock?
by Zacks Equity Research
EG gains from global growth, portfolio strength and a solid balance sheet, but faces weak ROE and catastrophe exposure.
EverQuote Trades Above 200-Day SMA: Time to Buy the Stock?
by Zacks Equity Research
EVER trades above its 200-day SMA with strong returns and rising quote requests, though challenges remain ahead.
Wall Street Analysts Predict a 36.57% Upside in EverQuote (EVER): Here's What You Should Know
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 36.6% in EverQuote (EVER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
EverQuote Q2 Earnings & Revenues Beat on Higher Automotive Revenues
by Zacks Equity Research
EVER's second-quarter results reflect solid performances across both Automotive insurance and Home and Renters insurance verticals, offset by higher expenses.
Compared to Estimates, EverQuote (EVER) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for EverQuote (EVER) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
EverQuote (EVER) Beats Q2 Earnings Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of +11.43% and -0.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
EverQuote Set to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
EVER eyes 34% revenue growth and a 106% EPS jump in Q2, fueled by market recovery and platform-driven demand gains.
EVER Rallies 27% YTD, Trades at Premium: Should You Buy the Stock?
by Zacks Equity Research
EverQuote gains 26.9% YTD, outperforming its industry as platform expansion and acquisitions fuel strong growth.
PRU Stock Trading at a Discount to Industry at 7.47X: Time to Buy?
by Zacks Equity Research
Prudential Financial lags the market with a 10.1% drop but trades at a discount, backed by solid ROE and a global growth strategy.
Can Assurant and Plug Elevate the Pre-Owned Tech Experience?
by Zacks Equity Research
AIZ teams up with Plug to scale device protection, cut e-waste, and tap new growth in the booming pre-owned tech market.
Can Prudential's New ActiveIncome Feature Redefine Retirement Planning?
by Zacks Equity Research
PRU debuts ActiveIncome, an annuity overlay for managed accounts that offers lifetime income without sacrificing liquidity.
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
by Sanghamitra Saha
EVER, MAMA, and SFM stand out in a DuPont-driven screen with strong profit margins, asset efficiency, and moderate leverage.